KRRO Latest Press Releases

-- November 6, 2026 --

Korro to Present at the 2026 Jefferies Global Healthcare Conference in London Globe Newswire 7:00 AM

-- November 5, 2026 --

Korro Reports Third Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire 7:00 AM

-- October 22, 2026 --

Korro Reports Best-in-Class Preclinical Data for KRRO-111 Demonstrating Potential to Benefit Lung and Liver Manifestations of Alpha-1 Antitrypsin Deficiency Globe Newswire 7:00 AM

-- October 16, 2026 --

Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- October 5, 2026 --

Korro Announces First Cohort Dosed in Phase 1/2 Clinical Trial (ANCHOR) for KRRO-121 Globe Newswire 4:05 PM

-- September 11, 2026 --

Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:04 PM

-- August 27, 2026 --

Korro to Participate in Upcoming Investor Conferences Globe Newswire 7:00 AM

-- August 14, 2026 --

Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- August 6, 2026 --

Korro Reports Second Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire 7:00 AM

-- July 10, 2026 --

Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

Market Data Delayed 15 Minutes